Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04790240 · ClinicalTrials.gov registry record · Phase 1
Medical Herbs Inhibit Inflammation Directing T Cells to Kill the COVID-19 Virus (COVID)
A Phase 1 study of Covid19 Virus Infection, sponsored by All Natural Medicine Clinic.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT04790240 is a Phase 1 study of Covid19 Virus Infection that is actively recruiting participants, run by All Natural Medicine Clinic. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04790240, a Phase 1 study of Covid19 Virus Infection, is actively recruiting participants, sponsored by All Natural Medicine Clinic.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The human immune system is designed to protect individuals from external sources of infection and internal cell mutation. It works effectively and efficiently until inflammation disturbs its functioning. Once compromised by inflammation, the immune system loses its capacity to recognize antigens and dependably defend the body against disease and illness. When COVID-19 invades humans, it causes an immune-storm (cytokine-storm) that can directly damage the organ(s), leading to death. The virus is an antigen - a trigger - but it is not the actual reason that causes organ failure and death; instead, it is the body's over immune reaction that is the cause. In attempting to protect the body, the immune system overreacts to the antigen, which includes the infected cells, which causes a cytokine-storm, and the subsequent and rapid shut down of the infected individual's organ(s)' structure, leaving the body without sufficient strength or time to fight back. When the medical herbs join the body, it can slow down the immune reaction. Medical herbs benefit the physical body; they protect the cells and organism structure and mediate the immune response, allowing the T cells to kill the virus (mutated or not) internally. Such success has been achieved by the All Natural Medicine Clinic during pre-clinical trials. This clinical study's goal is to demonstrate that the immune system can be rebuilt and retrained, using natural medicine (i.e., medical herbs), to kill the virus without causing the immune storm, and to explore the mechanism by which these medical herbs, which have been used for thousands of years for healing, achieve results.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Inflammation (I)
- DIETARY_SUPPLEMENT Inflammation (II)
- DIETARY_SUPPLEMENT Inflammation (III)
- DRUG Standard of care
Study Locations (1)
Maryland
- All Natural Medicine Clinic, LLC - Rockville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-01-01 |
| Est. Completion | 2027-05-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04790240
The ClinicalTrials.gov registry entry for NCT04790240 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is All Natural Medicine Clinic, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Covid19 Virus Infection appearing as the primary indexed condition, and to 4 interventions - of which Inflammation (I) is the first listed.
NCT04790240 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT04790240 about?
NCT04790240 is a clinical study titled "Medical Herbs Inhibit Inflammation Directing T Cells to Kill the COVID-19 Virus (COVID)". The human immune system is designed to protect individuals from external sources of infection and internal cell mutation. It works effectively and efficiently until inflammation disturbs its functioning. Once compromised by inflammation, the immune system loses its capacity to recognize antigens and...
What is the current status of trial NCT04790240?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 100 participants. The study started on 2025-01-01. Estimated completion is 2027-05-30.
What conditions does trial NCT04790240 study?
This clinical trial studies the following conditions: Covid19 Virus Infection.
What interventions are being tested in trial NCT04790240?
The interventions under investigation include: Inflammation (I) (DIETARY_SUPPLEMENT), Inflammation (II) (DIETARY_SUPPLEMENT), Inflammation (III) (DIETARY_SUPPLEMENT), Standard of care (DRUG).
Who is sponsoring clinical trial NCT04790240?
This trial is sponsored by All Natural Medicine Clinic, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04790240 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.